Overview

Study to Evaluate Analgesic Effect of IV Administration of Kappa Agonist CR845 For Hysterectomy Surgery

Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to determine if CR845 is effective in treating the pain associated with a laparoscopic hysterectomy.
Phase:
Phase 2
Details
Lead Sponsor:
Cara Therapeutics, Inc.
Treatments:
Analgesics
Peripheral Nervous System Agents